Welcome to Restore the Man
The Restore the Man program is dedicated to connecting and informing the UK community of healthcare practitioners and clinical specialists involved in the treatment of hypogonadism.
References
- Dohle GR et al. EAU Guidelines. 2018: Arnhem, the Netherlands. Return to content
- Kumar P et al. J Adv Pharm Technol Res. 2010 Jul-Sep; 1(3): 297–301. Return to content
- Hackett G et al. The British Society for Sexual Medicine guidelines on adult testosterone deficiency with statements for UK practice. J Sex Med 2017;14:1504- 23. Return to content
- http://www.bssm.org.uk/wp-content/uploads/2018/02/BSSM-Practical-Guide-High-Res-single-pp-view-final.pdf Return to content
Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk.
Adverse events should also be reported to Bayer plc, Tel: 01182063500, Fax: 01182063703, Email: pvuk@bayer.com.
If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc, Email: qualitycomplaints@bayer.com
For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.
Restore the man is organised and funded by Bayer and may contain some promotional content.
Licensed for: In the UK, Nebido® (testosterone undecanoate) is Licensed for testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.
Nebido® (testosterone undecanoate) Prescribing Information
This website is intended for Healthcare Professionals resident in the UK.
Page last modified 14 Jun 2021
- PP-NEB-GB-0508 April 2022
